Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Choice of cholesterol-lowering drugs.

[No authors listed]

Med Lett Drugs Ther. 1993 Mar 5;35(891):19-22. No abstract available.

PMID:
8433674
2.

Choice of cholesterol-lowering drugs.

[No authors listed]

Med Lett Drugs Ther. 1991 Jan 11;33(835):1-4. No abstract available.

PMID:
1984601
3.

Rational drug therapy of the hyperlipoproteinemias, Part II.

Blum CB, Levy RI.

Ration Drug Ther. 1986 Oct;20(10):1-4. No abstract available.

PMID:
3472266
4.

Lipid-lowering drugs.

[No authors listed]

Med Lett Drugs Ther. 1985 Aug 30;27(695):74-6. No abstract available.

PMID:
3860714
5.

Criteria for use of hypolipidemic agents in adults.

Morales E, Spinler SA, Wilson MD, Chin MM, Jozefiak E.

Am J Hosp Pharm. 1994 Nov 15;51(22):2837-41. No abstract available.

PMID:
7856612
6.

Current pharmacologic treatment of elevated serum cholesterol.

Tikkanen MJ, Nikkilä EA.

Circulation. 1987 Sep;76(3):529-33.

PMID:
3476221
7.

Current and new therapy for hypercholesterolemia.

Hunninghake DB.

J Am Osteopath Assoc. 1988 Jul;88(7):865-9. No abstract available.

PMID:
3215796
8.

Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.

Schulman KA, Kinosian B, Jacobson TA, Glick H, Willian MK, Koffer H, Eisenberg JM.

JAMA. 1990 Dec 19;264(23):3025-33. Review.

PMID:
2123013
9.

Lipid-lowering drugs.

Charlotte N, Sani M.

Nurs Older People. 2004 Dec;16(9):37-8. No abstract available.

PMID:
15617403
10.

New approaches to cholesterol lowering: efficacy and safety.

Knopp RH.

Hosp Pract (Off Ed). 1988 Jun;23 Suppl 1:22-30. Review. No abstract available.

PMID:
3134382
11.

Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.

Corvol JC, Bouzamondo A, Sirol M, Hulot JS, Sanchez P, Lechat P.

Arch Intern Med. 2003 Mar 24;163(6):669-76. Review.

PMID:
12639199
12.
13.

New guidelines for managing hypercholesterolemia. National Cholesterol Education Program.

McKenney JM.

Am Pharm. 1993 Jul;NS33(7):24-32. No abstract available.

PMID:
8342492
14.

Choosing the right lipid-regulating agent. A guide to selection.

Farmer JA, Gotto AM Jr.

Drugs. 1996 Nov;52(5):649-61. Review.

PMID:
9118815
15.

[Disorders of lipid metabolism--diagnosis and therapy in general practice. 4: Therapy of hypercholesterolemia--drug treatment].

Richter WO.

Fortschr Med. 1996 May 20;114(14):177-8. German. No abstract available.

PMID:
8707237
16.

Choice of lipid-regulating drugs.

[No authors listed]

Med Lett Drugs Ther. 2001 May 28;43(1105):43-8. No abstract available.

PMID:
11378632
18.

Reducing cardiac deaths with hypolipidemic drugs.

Naito HK.

Postgrad Med. 1987 Nov 1;82(6):102-12. Review. No abstract available.

PMID:
3313343
19.

Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.

Eriksson M, Hådell K, Holme I, Walldius G, Kjellström T.

J Intern Med. 1998 May;243(5):373-80.

20.

When to treat hyperlipidemia.

Kane JP, Malloy MJ.

Adv Intern Med. 1988;33:143-63. Review. No abstract available.

PMID:
3278503

Supplemental Content

Support Center